Tag Archives: Epizyme

November, 2018

September, 2018

June, 2016

  • 24 June

    Epizyme and Genentech Partner to Assess Drug Combo in NHL

    CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, Inc. (NASDAQ: EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies for people with cancer, announced today it has entered into a collaboration agreement with Genentech, a member of the Roche Group, to conduct a clinical trial to investigate the anti-cancer effects of Epizyme’s EZH2 inhibitor, tazemetostat, …

December, 2015